Učitavanje...
Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer
INTRODUCTION: Testosterone suppression, or androgen-deprivation therapy (ADT), is an established treatment for recurrent and metastatic prostate cancer (PCa). Based on the accuracy and sensitivity of early assays (c. 1960–1970), the castrate testosterone level was set at ≤1.7 nmol/l. Improved sensit...
Spremljeno u:
| Izdano u: | Can Urol Assoc J |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Canadian Medical Association
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5403681/ https://ncbi.nlm.nih.gov/pubmed/28443139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4303 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|